Babao, Darwin, Jr. C.
HRN: 27-91-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
10/19/2025
10/26/2025
IV
22mg LD, 11mg MD
Q 24
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes